APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transfusion Diagnosis for Donor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Transfusion Diagnosis for Donor Industry Growth and Trends Forecast to 2032

Report ID 174259800115 January 2026101 pages

Choose your research edition.

Industry ResearchTransfusion Diagnosis for Donor Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Transfusion Diagnosis for Donor Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Transfusion Diagnosis for Donor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transfusion Diagnosis for Donor Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Transfusion Diagnosis for Donor Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global Transfusion Diagnosis for Donor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Transfusion Diagnosis for Donor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Transfusion Diagnosis for Donor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transfusion Diagnosis for Donor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Transfusion Diagnosis for Donor market include Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH and Diasorin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Transfusion Diagnosis for Donor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Transfusion Diagnosis for Donor market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transfusion Diagnosis for Donor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transfusion Diagnosis for Donor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Transfusion Diagnosis for Donor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Transfusion Diagnosis for Donor Market by Company

Grifols

F. Hoffmann-La Roche

Abbott

Bio-Rad Laboratories

Werfen

QuidelOrtho Corporation

AliveDx Holdings Finance

BAG Diagnostics GmbH

Diasorin

Prestige Diagnostics

Atlas Medical GmbH

Lorne Laboratories

Transfusion Diagnosis for Donor Segment by Type

Instruments

Kits and Reagents

Transfusion Diagnosis for Donor Segment by Application

Blood Banks

Blood Donation/Transfusion Centers

Others

Transfusion Diagnosis for Donor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transfusion Diagnosis for Donor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transfusion Diagnosis for Donor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transfusion Diagnosis for Donor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Transfusion Diagnosis for Donor companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Transfusion Diagnosis for Donor Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Transfusion Diagnosis for Donor Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Transfusion Diagnosis for Donor Market Share by Region (2021-2026) Table 4. Global Transfusion Diagnosis for Donor Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Transfusion Diagnosis for Donor Market Share by Region (2027-2032) Table 6. Global Transfusion Diagnosis for Donor Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Transfusion Diagnosis for Donor Market Size Share by Type (2021-2026) Table 9. Global Transfusion Diagnosis for Donor Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Transfusion Diagnosis for Donor Market Size Share Forecasted by Type (2027-2032) Table 11. North America Transfusion Diagnosis for Donor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Transfusion Diagnosis for Donor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Transfusion Diagnosis for Donor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Transfusion Diagnosis for Donor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Transfusion Diagnosis for Donor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Transfusion Diagnosis for Donor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Transfusion Diagnosis for Donor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Transfusion Diagnosis for Donor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Transfusion Diagnosis for Donor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Transfusion Diagnosis for Donor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Transfusion Diagnosis for Donor Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Transfusion Diagnosis for Donor Market Size Share by Application (2021-2026) Table 24. Global Transfusion Diagnosis for Donor Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Transfusion Diagnosis for Donor Market Size Share Forecasted by Application (2027-2032) Table 26. North America Transfusion Diagnosis for Donor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Transfusion Diagnosis for Donor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Transfusion Diagnosis for Donor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Transfusion Diagnosis for Donor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Transfusion Diagnosis for Donor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Transfusion Diagnosis for Donor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Transfusion Diagnosis for Donor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Transfusion Diagnosis for Donor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Transfusion Diagnosis for Donor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Transfusion Diagnosis for Donor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Transfusion Diagnosis for Donor Industry Trends Table 37. Transfusion Diagnosis for Donor Industry Drivers Table 38. Transfusion Diagnosis for Donor Industry Opportunities and Challenges Table 39. Transfusion Diagnosis for Donor Industry Restraints Table 40. Global Transfusion Diagnosis for Donor Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Transfusion Diagnosis for Donor Revenue Market Share by Company (2021-2026) Table 42. Global Transfusion Diagnosis for Donor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Transfusion Diagnosis for Donor Key Company Headquarters & Area Served Table 44. Global Transfusion Diagnosis for Donor Company, Product Type & Application Table 45. Global Transfusion Diagnosis for Donor Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Transfusion Diagnosis for Donor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Grifols Company Information Table 49. Grifols Business Overview Table 50. Grifols Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Grifols Transfusion Diagnosis for Donor Product Portfolio Table 52. Grifols Recent Development Table 53. F. Hoffmann-La Roche Company Information Table 54. F. Hoffmann-La Roche Business Overview Table 55. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Portfolio Table 57. F. Hoffmann-La Roche Recent Development Table 58. Abbott Company Information Table 59. Abbott Business Overview Table 60. Abbott Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Abbott Transfusion Diagnosis for Donor Product Portfolio Table 62. Abbott Recent Development Table 63. Bio-Rad Laboratories Company Information Table 64. Bio-Rad Laboratories Business Overview Table 65. Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Portfolio Table 67. Bio-Rad Laboratories Recent Development Table 68. Werfen Company Information Table 69. Werfen Business Overview Table 70. Werfen Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Werfen Transfusion Diagnosis for Donor Product Portfolio Table 72. Werfen Recent Development Table 73. QuidelOrtho Corporation Company Information Table 74. QuidelOrtho Corporation Business Overview Table 75. QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Portfolio Table 77. QuidelOrtho Corporation Recent Development Table 78. AliveDx Holdings Finance Company Information Table 79. AliveDx Holdings Finance Business Overview Table 80. AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Portfolio Table 82. AliveDx Holdings Finance Recent Development Table 83. BAG Diagnostics GmbH Company Information Table 84. BAG Diagnostics GmbH Business Overview Table 85. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Portfolio Table 87. BAG Diagnostics GmbH Recent Development Table 88. Diasorin Company Information Table 89. Diasorin Business Overview Table 90. Diasorin Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Diasorin Transfusion Diagnosis for Donor Product Portfolio Table 92. Diasorin Recent Development Table 93. Prestige Diagnostics Company Information Table 94. Prestige Diagnostics Business Overview Table 95. Prestige Diagnostics Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Prestige Diagnostics Transfusion Diagnosis for Donor Product Portfolio Table 97. Prestige Diagnostics Recent Development Table 98. Atlas Medical GmbH Company Information Table 99. Atlas Medical GmbH Business Overview Table 100. Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Atlas Medical GmbH Transfusion Diagnosis for Donor Product Portfolio Table 102. Atlas Medical GmbH Recent Development Table 103. Lorne Laboratories Company Information Table 104. Lorne Laboratories Business Overview Table 105. Lorne Laboratories Transfusion Diagnosis for Donor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Lorne Laboratories Transfusion Diagnosis for Donor Product Portfolio Table 107. Lorne Laboratories Recent Development Table 108. North America Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Transfusion Diagnosis for Donor Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Transfusion Diagnosis for Donor Market Share by Country (2021-2026) Table 111. North America Transfusion Diagnosis for Donor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Transfusion Diagnosis for Donor Market Share Forecast by Country (2027-2032) Table 113. Europe Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Transfusion Diagnosis for Donor Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Transfusion Diagnosis for Donor Market Share by Country (2021-2026) Table 116. Europe Transfusion Diagnosis for Donor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Transfusion Diagnosis for Donor Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Transfusion Diagnosis for Donor Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Transfusion Diagnosis for Donor Market Share by Country (2021-2026) Table 121. Asia-Pacific Transfusion Diagnosis for Donor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Transfusion Diagnosis for Donor Market Share Forecast by Country (2027-2032) Table 123. Latin America Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Transfusion Diagnosis for Donor Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Transfusion Diagnosis for Donor Market Share by Country (2021-2026) Table 126. Latin America Transfusion Diagnosis for Donor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Transfusion Diagnosis for Donor Market Share Forecast by Country (2027-2032) Table 128. Middle East & Africa Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East & Africa Transfusion Diagnosis for Donor Market Share by Country (2021-2026) Table 131. Middle East & Africa Transfusion Diagnosis for Donor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East & Africa Transfusion Diagnosis for Donor Market Share Forecast by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Transfusion Diagnosis for Donor Product Image Figure 3. Global Transfusion Diagnosis for Donor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 5. Global Transfusion Diagnosis for Donor Market Share by Region: 2025 VS 2032 Figure 6. Global Transfusion Diagnosis for Donor Market Share by Region (2021-2032) Figure 7. North America Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Instruments Image Figure 13. Global Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Kits and Reagents Image Figure 15. Global Kits and Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Transfusion Diagnosis for Donor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Transfusion Diagnosis for Donor Market Share by Type 2025 VS 2032 Figure 18. North America Transfusion Diagnosis for Donor Market Size Share by Type (2021-2032) Figure 19. Europe Transfusion Diagnosis for Donor Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Transfusion Diagnosis for Donor Market Size Share by Type (2021-2032) Figure 21. Latin America Transfusion Diagnosis for Donor Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Transfusion Diagnosis for Donor Market Size Share by Type (2021-2032) Figure 23. Blood Banks Image Figure 24. Global Blood Banks Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Blood Donation/Transfusion Centers Image Figure 26. Global Blood Donation/Transfusion Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Transfusion Diagnosis for Donor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Transfusion Diagnosis for Donor Market Share by Application 2025 VS 2032 Figure 31. North America Transfusion Diagnosis for Donor Market Size Share by Application (2021-2032) Figure 32. Europe Transfusion Diagnosis for Donor Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Transfusion Diagnosis for Donor Market Size Share by Application (2021-2032) Figure 34. Latin America Transfusion Diagnosis for Donor Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Transfusion Diagnosis for Donor Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Transfusion Diagnosis for Donor Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Transfusion Diagnosis for Donor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Transfusion Diagnosis for Donor Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Transfusion Diagnosis for Donor Market Share by Country (2021-2032) Figure 41. Europe Transfusion Diagnosis for Donor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Transfusion Diagnosis for Donor Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Transfusion Diagnosis for Donor Market Share by Country (2021-2032) Figure 44. Asia-Pacific Transfusion Diagnosis for Donor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Transfusion Diagnosis for Donor Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Transfusion Diagnosis for Donor Market Share by Country (2021-2032) Figure 47. Latin America Transfusion Diagnosis for Donor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Transfusion Diagnosis for Donor Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Transfusion Diagnosis for Donor Market Share by Country (2021-2032) Figure 50. Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Transfusion Diagnosis for Donor Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Transfusion Diagnosis for Donor Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Instruments
  • Kits and Reagents
Applications
  • Blood Banks
  • Blood Donation/Transfusion Centers
  • Others
Companies covered
  • Grifols
  • F. Hoffmann-La Roche
  • Abbott
  • Bio-Rad Laboratories
  • Werfen
  • QuidelOrtho Corporation
  • AliveDx Holdings Finance
  • BAG Diagnostics GmbH
  • Diasorin
  • Prestige Diagnostics
  • Atlas Medical GmbH
  • Lorne Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Transfusion Diagnosis for Donor Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Transfusion Diagnosis for Donor Market Size by Region (2021-2032)
  5. 1.4.1 Global Transfusion Diagnosis for Donor Market Size by Region (2021-2026)
  6. 1.4.2 Global Transfusion Diagnosis for Donor Market Size by Region (2027-2032)
  7. 1.5 Key Regions Transfusion Diagnosis for Donor Market Size (2021-2032)
  8. 1.5.1 North America Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032)
2 Transfusion Diagnosis for Donor Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Instruments
  3. 2.1.2 Kits and Reagents
  4. 2.2 Global Transfusion Diagnosis for Donor Market Size by Type
  5. 2.2.1 Global Transfusion Diagnosis for Donor Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Transfusion Diagnosis for Donor Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Transfusion Diagnosis for Donor Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Transfusion Diagnosis for Donor Market Size by Regions
  9. 2.3.1 North America Transfusion Diagnosis for Donor Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Transfusion Diagnosis for Donor Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Transfusion Diagnosis for Donor Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Transfusion Diagnosis for Donor Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Transfusion Diagnosis for Donor Market Size Breakdown by Type (2021-2026)
3 Transfusion Diagnosis for Donor Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Blood Banks
  3. 3.1.2 Blood Donation/Transfusion Centers
  4. 3.1.3 Others
  5. 3.2 Global Transfusion Diagnosis for Donor Market Size by Application
  6. 3.2.1 Global Transfusion Diagnosis for Donor Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Transfusion Diagnosis for Donor Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Transfusion Diagnosis for Donor Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Transfusion Diagnosis for Donor Market Size by Regions
  10. 3.3.1 North America Transfusion Diagnosis for Donor Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Transfusion Diagnosis for Donor Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Transfusion Diagnosis for Donor Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Transfusion Diagnosis for Donor Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Transfusion Diagnosis for Donor Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Transfusion Diagnosis for Donor Industry Trends
  2. 4.2 Transfusion Diagnosis for Donor Industry Drivers
  3. 4.3 Transfusion Diagnosis for Donor Industry Opportunities and Challenges
  4. 4.4 Transfusion Diagnosis for Donor Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Transfusion Diagnosis for Donor Revenue (2021-2026)
  2. 5.2 Global Transfusion Diagnosis for Donor Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Transfusion Diagnosis for Donor Key Company Headquarters & Area Served
  4. 5.4 Global Transfusion Diagnosis for Donor Company, Product Type & Application
  5. 5.5 Global Transfusion Diagnosis for Donor Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Transfusion Diagnosis for Donor Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Transfusion Diagnosis for Donor Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Transfusion Diagnosis for Donor Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Grifols
  2. 6.1.1 Grifols Company Information
  3. 6.1.2 Grifols Business Overview
  4. 6.1.3 Grifols Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Grifols Transfusion Diagnosis for Donor Product Portfolio
  6. 6.1.5 Grifols Recent Developments
  7. 6.2 F. Hoffmann-La Roche
  8. 6.2.1 F. Hoffmann-La Roche Company Information
  9. 6.2.2 F. Hoffmann-La Roche Business Overview
  10. 6.2.3 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Portfolio
  12. 6.2.5 F. Hoffmann-La Roche Recent Developments
  13. 6.3 Abbott
  14. 6.3.1 Abbott Company Information
  15. 6.3.2 Abbott Business Overview
  16. 6.3.3 Abbott Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Abbott Transfusion Diagnosis for Donor Product Portfolio
  18. 6.3.5 Abbott Recent Developments
  19. 6.4 Bio-Rad Laboratories
  20. 6.4.1 Bio-Rad Laboratories Company Information
  21. 6.4.2 Bio-Rad Laboratories Business Overview
  22. 6.4.3 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Portfolio
  24. 6.4.5 Bio-Rad Laboratories Recent Developments
  25. 6.5 Werfen
  26. 6.5.1 Werfen Company Information
  27. 6.5.2 Werfen Business Overview
  28. 6.5.3 Werfen Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Werfen Transfusion Diagnosis for Donor Product Portfolio
  30. 6.5.5 Werfen Recent Developments
  31. 6.6 QuidelOrtho Corporation
  32. 6.6.1 QuidelOrtho Corporation Company Information
  33. 6.6.2 QuidelOrtho Corporation Business Overview
  34. 6.6.3 QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Portfolio
  36. 6.6.5 QuidelOrtho Corporation Recent Developments
  37. 6.7 AliveDx Holdings Finance
  38. 6.7.1 AliveDx Holdings Finance Company Information
  39. 6.7.2 AliveDx Holdings Finance Business Overview
  40. 6.7.3 AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Portfolio
  42. 6.7.5 AliveDx Holdings Finance Recent Developments
  43. 6.8 BAG Diagnostics GmbH
  44. 6.8.1 BAG Diagnostics GmbH Company Information
  45. 6.8.2 BAG Diagnostics GmbH Business Overview
  46. 6.8.3 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Portfolio
  48. 6.8.5 BAG Diagnostics GmbH Recent Developments
  49. 6.9 Diasorin
  50. 6.9.1 Diasorin Company Information
  51. 6.9.2 Diasorin Business Overview
  52. 6.9.3 Diasorin Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Diasorin Transfusion Diagnosis for Donor Product Portfolio
  54. 6.9.5 Diasorin Recent Developments
  55. 6.10 Prestige Diagnostics
  56. 6.10.1 Prestige Diagnostics Company Information
  57. 6.10.2 Prestige Diagnostics Business Overview
  58. 6.10.3 Prestige Diagnostics Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Prestige Diagnostics Transfusion Diagnosis for Donor Product Portfolio
  60. 6.10.5 Prestige Diagnostics Recent Developments
  61. 6.11 Atlas Medical GmbH
  62. 6.11.1 Atlas Medical GmbH Company Information
  63. 6.11.2 Atlas Medical GmbH Business Overview
  64. 6.11.3 Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Atlas Medical GmbH Transfusion Diagnosis for Donor Product Portfolio
  66. 6.11.5 Atlas Medical GmbH Recent Developments
  67. 6.12 Lorne Laboratories
  68. 6.12.1 Lorne Laboratories Company Information
  69. 6.12.2 Lorne Laboratories Business Overview
  70. 6.12.3 Lorne Laboratories Transfusion Diagnosis for Donor Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Lorne Laboratories Transfusion Diagnosis for Donor Product Portfolio
  72. 6.12.5 Lorne Laboratories Recent Developments
7 North America
  1. 7.1 North America Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
  3. 7.3 North America Transfusion Diagnosis for Donor Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
  3. 8.3 Europe Transfusion Diagnosis for Donor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Transfusion Diagnosis for Donor Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
  3. 10.3 South America Transfusion Diagnosis for Donor Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Transfusion Diagnosis for Donor Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst